It acts simultaneously on glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors, producing significant reductions in body weight and improvements in glycaemic control
Diarrhea and constipation also occur in significant percentages of the user population
Increased binding was present in the hippocampus, amygdala, thalamus, midbrain, pons, and cingulate cortex, although the exact area of the cingulate cortex was not defined
Legal Disclaimer: This article is for informational purposes only and does not constitute legal or medical advice
But like all drugs, Melanotan needs time to build up in a person's system, with n3glv saying it took him two weeks of 'loading' before he saw results